This brand name is authorized in Austria, Brazil, Hong Kong, Japan, Lithuania, Mexico, Poland, Romania
The drug SERMION contains one active pharmaceutical ingredient (API):
|
1
Nicergoline
UNII JCV8365FWN - NICERGOLINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C04AE02 | Nicergoline | C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AE Ergot alkaloids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 552820070070017 |
| Country: HK | Department of Health Drug Office | Identifier(s): 06209, 19045, 33548 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2190021B1095, 2190021F1348 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1014505, 1014506, 1018881, 1061425 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 453M2001 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100060789, 100060803 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67204001, W67204002, W67204003 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
